Literature DB >> 22847332

Inflammation in muscular dystrophy and the beneficial effects of non-steroidal anti-inflammatory drugs.

Filippo Serra1, Marco Quarta, Marta Canato, Luana Toniolo, Valeria De Arcangelis, Attilio Trotta, Lucia Spath, Lucia Monaco, Carlo Reggiani, Fabio Naro.   

Abstract

INTRODUCTION: Glucocorticoids are the only drugs available for the treatment of Duchenne muscular dystrophy (DMD), but it is unclear whether their efficacy is dependent on their anti-inflammatory activity.
METHODS: To address this issue, mdx mice were treated daily with methylprednisolone and non-steroidal anti-inflammatory drugs (NSAIDs: aspirin, ibuprofen, parecoxib).
RESULTS: NSAID treatment was effective in ameliorating muscle morphology and reducing macrophage infiltration and necrosis. The percentage of regenerating myofibers was not modified by the treatments. The drugs were effective in reducing COX-2 expression and inflammatory cytokines, but they did not affect utrophin levels. The effects of the treatments on contractile performance were analyzed. Isometric tension did not differ in treated and untreated muscle, but the resistance to fatigue was decreased by treatment with methylprednisolone and aspirin.
CONCLUSIONS: NSAIDs have a beneficial effect on mdx muscle morphology, pointing to a crucial role of inflammation in the progression of DMD.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22847332     DOI: 10.1002/mus.23432

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  23 in total

1.  Photobiomodulation therapy protects skeletal muscle and improves muscular function of mdx mice in a dose-dependent manner through modulation of dystrophin.

Authors:  Gianna Móes Albuquerque-Pontes; Heliodora Leão Casalechi; Shaiane Silva Tomazoni; Andrey Jorge Serra; Cheila de Sousa Bacelar Ferreira; Rodrigo Barbosa de Oliveira Brito; Brunno Lemes de Melo; Adriane Aver Vanin; Kadma Karênina Damasceno Soares Monteiro; Humberto Dellê; Lucio Frigo; Rodrigo Labat Marcos; Paulo de Tarso Camillo de Carvalho; Ernesto Cesar Pinto Leal-Junior
Journal:  Lasers Med Sci       Date:  2017-12-05       Impact factor: 3.161

2.  Cyclooxygenase-2 or tumor necrosis factor-α inhibitors attenuate the mechanotransductive effects of pulsed focused ultrasound to suppress mesenchymal stromal cell homing to healthy and dystrophic muscle.

Authors:  Pamela A Tebebi; Scott R Burks; Saejeong J Kim; Rashida A Williams; Ben A Nguyen; Priyanka Venkatesh; Victor Frenkel; Joseph A Frank
Journal:  Stem Cells       Date:  2015-04       Impact factor: 6.277

3.  Multi-parametric MRI characterization of inflammation in murine skeletal muscle.

Authors:  Nathan D Bryant; Ke Li; Mark D Does; Stephanie Barnes; Daniel F Gochberg; Thomas E Yankeelov; Jane H Park; Bruce M Damon
Journal:  NMR Biomed       Date:  2014-04-29       Impact factor: 4.044

Review 4.  Aberrant NLRP3 Inflammasome Activation Ignites the Fire of Inflammation in Neuromuscular Diseases.

Authors:  Christine Péladeau; Jagdeep K Sandhu
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

5.  The immune system in Duchenne muscular dystrophy: Friend or foe.

Authors:  S Armando Villalta; Amy S Rosenberg; Jeffrey A Bluestone
Journal:  Rare Dis       Date:  2015-02-23

6.  Initial pulmonary respiration causes massive diaphragm damage and hyper-CKemia in Duchenne muscular dystrophy dog.

Authors:  Akinori Nakamura; Masanori Kobayashi; Mutsuki Kuraoka; Katsutoshi Yuasa; Naoko Yugeta; Takashi Okada; Shin'ichi Takeda
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

7.  piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts.

Authors:  Mariana Loperfido; Susan Jarmin; Sumitava Dastidar; Mario Di Matteo; Ilaria Perini; Marc Moore; Nisha Nair; Ermira Samara-Kuko; Takis Athanasopoulos; Francesco Saverio Tedesco; George Dickson; Maurilio Sampaolesi; Thierry VandenDriessche; Marinee K Chuah
Journal:  Nucleic Acids Res       Date:  2015-12-17       Impact factor: 16.971

8.  Obscurin is required for ankyrinB-dependent dystrophin localization and sarcolemma integrity.

Authors:  Davide Randazzo; Emiliana Giacomello; Stefania Lorenzini; Daniela Rossi; Enrico Pierantozzi; Bert Blaauw; Carlo Reggiani; Stephan Lange; Angela K Peter; Ju Chen; Vincenzo Sorrentino
Journal:  J Cell Biol       Date:  2013-02-18       Impact factor: 10.539

9.  Superpulsed low-level laser therapy protects skeletal muscle of mdx mice against damage, inflammation and morphological changes delaying dystrophy progression.

Authors:  Ernesto Cesar Pinto Leal-Junior; Patrícia de Almeida; Shaiane Silva Tomazoni; Paulo de Tarso Camillo de Carvalho; Rodrigo Álvaro Brandão Lopes-Martins; Lucio Frigo; Jon Joensen; Mark I Johnson; Jan Magnus Bjordal
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

Review 10.  Advancements in stem cells treatment of skeletal muscle wasting.

Authors:  Mirella Meregalli; Andrea Farini; Clementina Sitzia; Yvan Torrente
Journal:  Front Physiol       Date:  2014-02-12       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.